JONATHAN BROUSE: Open Payments
NPI 1568960664 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 15 payments from 8 companies in 2025. Trend: 2023 $191 · 2024 $299 · 2025 $458
Food & beverage: $401Education: $57
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $163 |
| AERIN MEDICAL INC. | 1 | $97 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| GENZYME CORPORATION | 2 | $49 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Integra LifeSciences Corporation | 1 | $23 |
| Optinose US, Inc. | 1 | $17 |
Products named: NUCALA, DUPIXENT, VIVAER STYLUS, INSPIRE, ACCLARENT AERA, Xhance.
Industry payments across MO — which companies pay providers there.
